Ads
-
Related paper
- TELMISARTAN PLUS ATORVASTATIN INFLUENCE ON ARTERIAL HYPERTENSION COMBINED WITH OBESITY AND NONALCOHOLIC FATTY LIVER DISEASE
- Correction of Dyslipidemia in Patients with Coronary Heart Disease Combined with Nonalcoholic Fatty Liver Disease
- Quality of Life in Patients with Nonalcoholic Fatty Liver Disease in Combination with Essential Hypertension
- Prediction of course and progression of nonalcoholic fatty liver disease in patients with obesity and pathology of the biliary tract with the help of mathematical modeling
- The Influence of Nonalcoholic Fatty Liver Disease on the Platelet Hemostasis and Endothelial Function State in Patients with Stable Coronary Heart Disease
- Omentin-1 rs2274907 and resistin rs1862513 polymorphisms influence genetic susceptibility to nonalcoholic fatty liver disease
- Statistical Neural Networks in the Classification of Alcoholic Liver Disease and Nonalcoholic Fatty Liver Disease
- INFLUENCE OF URSODEOXY-CHOLIC ACID ON CLINICAL COURSE OF CHRONIC NON-CALCULOUS CHOLECYSTITIS ON THE BACKGROUND OF NONALCOHOLIC FATTY LIVER DISEASE AND METABOLIC SYNDROME
- Influence of Levocarnitin Treatment during a Stable Ischemic Heart Disease in Patients with Non-Alcoholic Fatty Liver Disease and Obesity
- The Distribution of Genotypes of Polymorphism A1166C of the Angiotensin II Type 1 Receptor Gene in Patients with Arterial Hypertension in Combination with Non-Alcohol Fatty Liver Disease